Misophonia Management in Adolescents and Young Adults

A systematic review of 21 studies finds that the evidence base for treating misophonia in adolescents and young adults is gradually strengthening, with Cognitive Behavioral Therapy emerging as the most common structured intervention. The work, led by researchers Tanya Singh and Satish Kumaraswamy, synthesizes a decade of research to map how clinical approaches to this undercharacterized condition are evolving.

From Anecdote to Method: A Review of the Evidence

Misophonia, characterized by intense emotional and physiological reactions to specific sounds like chewing or pen-clicking, significantly impacts the lives of young people. To understand what treatments work, Singh and Kumaraswamy systematically analyzed 21 studies published between 2013 and 2025. They searched four major databases—PubMed, ScienceDirect, ResearchGate, and Google Scholar—and assessed the quality of each study using standardized Joanna Briggs Institute tools. The reviewed literature included 15 case reports, three case series, one single-case experimental design, one non-randomized controlled trial, and only one randomized controlled trial.

This mix of study designs reveals the field’s developmental stage. The authors noted a clear, gradual trend: research is shifting from anecdotal, single-case descriptions toward more organized and replicable treatment protocols.

Cognitive Behavioral Therapy Leads the Way

The most consistent finding across the review is the central role of Cognitive Behavioral Therapy. CBT, which helps individuals modify thought patterns and behavioral responses to triggers, was the most frequently employed and discussed intervention. The analysis suggests that variants of CBT adapted for families are especially prominent. This makes clinical sense, as many trigger sounds occur in home environments, and family support is often vital for young people managing the condition.

Other approaches, including certain medications and audiological tools like sound generators, were present in the literature but occupied a different space. The review found these were primarily used as supplementary supports rather than first-line treatments. For instance, sound therapy might be integrated into a broader CBT plan to help with desensitization, but it is not typically a standalone solution for misophonia. This distinction is important for patients and clinicians navigating treatment options.

Practical Implications for Patients and Clinicians

For individuals seeking help, this review offers a clearer picture of the current standard of care. It indicates that seeking a mental health professional trained in CBT, particularly someone familiar with misophonia or similar sensory-processing challenges, is a strong starting point. The emphasis on family-adapted CBT also suggests that involving close family members in therapy can be beneficial. You can learn more about the impact of misophonia in professional settings in our related article, “Misophonia Awareness and Stress in Audiology Students”.

For clinicians and researchers, the review identifies critical gaps. The overwhelming reliance on case reports and series means the evidence lacks the rigor of large-scale controlled trials. The authors explicitly state that the available evidence is still limited. This calls for more structured studies with control groups and standardized outcome measures to firmly establish which interventions are most effective. Future research must also consider developmental factors, as the needs of a 10-year-old likely differ from those of a 30-year-old.

The findings connect to a broader theme in auditory health: the need for integrated, brain-centered approaches. While misophonia is distinct from conditions like tinnitus or hyperacusis, they all involve complex brain networks processing sound and emotion. Research into predicting tinnitus treatment response with brain biomarkers reflects a similar push toward personalized, neuroscience-informed care. Furthermore, understanding related auditory conditions is key; for example, studies on P2x2 receptor antagonists reducing hyperacusis sensitivity explore pharmacological pathways that may one day inform misophonia research.

A Foundation for Future Research

The work by Singh and Kumaraswamy provides a necessary consolidation of a scattered field. By mapping the existing intervention landscape, they have created a foundation upon which more robust research can be built. Their conclusion is measured: progress is being made, but much work remains.

The shift from purely descriptive reports toward testable methods is an encouraging sign for the field. It suggests that misophonia is being taken seriously as a research and clinical entity. As more structured trials are conducted—potentially building on frameworks like the process-based misophonia treatment explored in a recent pilot—the hope is that evidence-based guidelines will become clearer for the young people and families affected by this challenging condition.

The source systematic review, “Interventions for Misophonia in Adolescents and Young Adults: A Systematic Review,” by Tanya Singh and Satish Kumaraswamy, is available via DOI 10.61096/ijamscr.v14.iss2.2026.1093-1111.